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Abstract 
Background: High levels of ex vivo CD4 T‑cell death and the accumulation of highly differentiated and/or immu‑
nosenescent T cells have been associated with poor CD4 T‑cell recovery in treated HIV‑infected individuals. However, 
the relationship between cell death and T‑cell differentiation is still unclear.
Methods: We have analyzed cell death, immunosenescence and differentiation parameters in HAART‑treated sub‑
jects (VL <50 copies/mL for more than 2 years) with CD4 T‑cell count <350 cells/μL (immunodiscordant, n = 23) or 
>400 cells/μL (immunoconcordant, n = 33). We included 11 healthy individuals as reference.
Results: As expected, suboptimal CD4 T‑cell recovery was associated with low frequencies of naïve cells, high 
frequencies of transitional and effector memory cells and a subsequent low ratio of central/transitional memory cells 
in the CD4 compartment. These alterations correlated with spontaneous CD4 T‑cell death. A deeper analysis of cell 
death in CD4 T‑cell subsets showed increased cell death in memory cells of immunodiscordant individuals, mainly 
affecting central memory cells. Immunosenescence was also higher in immunodiscordant individuals albeit unrelated 
to cell death. The CD8 compartment was similar in both HIV‑infected groups, except for an underrepresentation of 
naïve cells in immunodiscordant individuals.
Conclusion: Immunodiscordant individuals show alterations in memory CD4 T‑cell differentiation associated with a 
short ex vivo lifespan of central memory cells and an in vivo low central/transitional memory cell ratio. These altera‑
tions may contribute to poor CD4 T‑cell repopulation.
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Background
HIV-1 infection leads to major perturbations of immune 
regulatory mechanisms [1] as a consequence of virus-
mediated depletion of CD4 T cells [2, 3] and increased 
immune activation and inflammation [1]. Abnormal pro-
liferative responses, maturation and immunosenescence 
of T cells, affecting both CD4 and CD8 compartments 
and covering acute, chronic and late stages of infection 
have been reported [4].
Highly active antiretroviral therapy (HAART) effi-
ciently controls HIV-1 replication, but inflammatory sta-
tus and immune activation remain abnormally high in 
treated individuals compared with uninfected individuals 
[1]. Furthermore, CD4 T-cell recovery shows a hetero-
geneous response [5, 6]; while some subjects reach CD4 
T-cell counts comparable to healthy individuals, others 
fail to increase CD4 T-cell counts even after long-term 
(>5  years) virologically effective treatment [5, 7]. This 
immunodiscordant response has been associated with 
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immunological damage induced by HIV-1 replication 
measured by nadir CD4 T-cell counts [7, 8] and specifi-
cally with the destruction of thymic tissue and the con-
sequent lack of production of new naïve cells [9, 10]. 
However, in the absence of new T cells, memory cells can 
repopulate the CD4 T-cell compartment in non-human 
primate models of HIV infection [11], suggesting that the 
damage of memory cells may also contribute to blunted 
immunological recoveries.
Increased replicative senescence, measured by the 
senescence marker CD57 [12], have been related with 
immune recovery [13] and could affect CD4 T cells in 
both naïve and memory subsets [14]. Apart from repli-
cative senescence, skewed maturation of memory CD4 T 
cells [15] and higher turnover and sensitivity to sponta-
neous cell death [9, 15] may contribute to a lower pro-
liferative potential of memory cells leading to incomplete 
immune recovery under HAART. However, it is still 
unclear how these different alterations of memory cells 
are linked and how are they associated with thymic dam-
age or senescence. Moreover, the specific role of central 
memory CD4 T cells, a major player of HIV pathogenesis 
[16], in immune recovery remains poorly defined.
Considering the role of CD4 T-cell death in immuno-
logical recovery on HAART [6], we sought to analyze 
its relationship with altered maturation/immunosenes-
cence profiles of memory cells. Therefore, we designed a 
study to compare these parameters in subjects with low 
and high CD4 T-cell recovery after long-term successful 
HAART. An aberrant maturation phenotype defined by 
a reduced central/transitional memory CD4 T-cell ratio, 
but not immunosenescence, strongly correlated with 
poor CD4 T-cell recovery and seems to be associated 
with high cell death levels in intermediate differentiation 
stages of memory cells.
Methods
Samples
A cross-sectional study was performed to analyze the 
level of immunosenescence and differentiation of T cells 
in HAART-treated subjects. The Institutional Review 
Board of the Hospital Germans Trias i Pujol approved 
the study (EO code: EO-07-024) and all individuals pro-
vided written informed consent. Subjects that partici-
pated in the APOP-V+I− study [8, 17] were screened for 
the current study: 56 individuals with at least two frozen 
aliquots of PBMCs were selected. All subjects had con-
firmed diagnosis of HIV infection, continuous HAART 
with plasma viral load <50  copies/mL for at least the 
last 2  years (minimum of 4 determinations during this 
period) and good treatment adherence. Exclusion crite-
ria were: chemotherapy or interferon/ribavirin treatment 
and history of opportunistic infections during the last 
2 years.
Patients were classified as Concordant (favorable viro-
logic and immunologic response) when CD4 T-cell 
counts were above 400 cells/μL. Conversely, Discordant 
patients (favorable virologic but unsatisfactory immu-
nologic response) showed CD4 T cells <350  cells/μL 
[8, 17]. Clinical and demographic data were collected 
from medical records. For comparative purposes, frozen 
PBMC from a control group of HIV uninfected individu-
als (n = 11; EO-10-007, Institutional Review Board of the 
Hospital Germans Trias i Pujol) were also analyzed.
CD4 and CD8 T‑cell immunophenotype
Frozen PBMCs were thawed at 37°C, washed twice in 
RPMI/20% of fetal bovine serum (FBS) and incubated for 
1  h at 37°C before staining with a previously described 
eight-color panel [18] including CD3-APC-Cy7, CD4-
PerCP-Cy5.5, CD8-V500, CD57-FITC, CD27-APC, 
CD28-PE, CCR7-PE-Cy7 and CD45RA-V450 (BD Bio-
sciences). Cell viability was evaluated by Propidium 
Iodide (PI, Sigma-Aldrich) staining in parallel tubes, the 
median [IQR] of PI+ cells was 2.1% [1.5–4.0]. Lymphocyte 
gate was defined by morphological parameters excluding 
most dead cells (less than 0.1% of PI+ cells were found in 
the living lymphocyte gate). At least 300,000 lymphocytes 
were acquired in a LSRII cytometer (BD Biosciences) 
and analyzed with FlowJo software (Tree Star). Gating 
strategy is described in Additional file 1: Figure S1. Rep-
licative senescence was defined by CD57+CD28− cells. 
T-cell subsets were first analyzed for CD27 and CD28 
expression to identify Terminally Differentiated cells 
(TTD, CD28−CD27−) and Effector Memory cells (TEM, 
CD27−CD28+ for CD4 T cells or CD27+CD28− for CD8 
T cells). Double positive CD27+CD28+ cells were suba-
nalyzed for CD45RA and CCR7 expression allowing for 
the definition of naive (TN, CD45RA+CCR7+), cen-
tral memory (TCM, CD45RA−CCR7+) and transitional 
memory cells (TTM, CD45RA−CCR7−). For each subset 
the expression of CD57 was analyzed (Additional file  1: 
Figure S1).
Immune activation, absolute lymphocyte counts (used 
to calculate absolute counts of each subset) and thymic 
production (CD45RA+CD31+CD4 T cells) were previ-
ously assessed in fresh blood samples in both CD4 and 
CD8 T cells [8, 17].
Ex vivo culture of whole PBMC and sorted cells
Data on spontaneous CD4 and CD8 T-cell death (includ-
ing necrosis, intrinsic and extrinsic apoptosis) have been 
previously reported and were obtained after culture of 
freshly obtained PBMC for 24  h [17, 19]. Furthermore, 
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in a subgroup of patients (n  =  10) freshly obtained 
PBMC were stained with CD3-APC-Cy7, CD4-PerCP-
Cy5.5, CD8-V500, CD27-APC, CCR7-PE-Cy7 and 
CD45RA-V450 as described above, washed in PBS and 
sorted immediately in a FACSAria (BD Biosciences) to 
obtain gated CD3+CD4+CD8− cells with the follow-
ing phenotypes: TN cells (CD27+CD45RA+CCR7+), 
TCM cells (CD27+CD45RA−CCR7+), TTM cells 
(CD27+CD45RA−CCR7−) and a mixture of TEM and TTD 
cells (TEM+TD CD27–). These latter subsets were sorted as 
a single population due to technical limitations of sorting 
procedure (only 4 sorted populations could be obtained 
from a single sample). Sorted cells were cultured for 
24 h and cell death was assayed using 40 nM DIOC(6) as 
described previously [19]. DIOC(6)low cells, having lost 
mitochondrial membrane potential, were identified as 
dead cells.
Statistical analysis
Continuous variables were expressed as the median 
(interquartile range) and compared using Mann–Whit-
ney U test, permutation test for unbalanced groups or 
Signed-Rank test (for paired analyses). Discrete vari-
ables were described as percentages and compared using 
the Fisher´s exact test. Correlations were assessed by the 
Spearman’s test. Multiple comparisons were adjusted for 
false discovery rate. Statistical analyses were performed 
using R software version 3.0.2 [20] with two-tailed sig-
nificance levels of 5%.
Results
Subject characteristics
Subjects recruited in this study were stratified according 
to the level of recovery of CD4 T cells after suppressive 
HAART, as immunodiscordant or immunoconcordant 
(cutoff value 350 CD4 T cells/μL). The time course of 
CD4 T-cell recovery for each group is shown in Figure 1a. 
At the time of sample analysis, the median CD4 T-cell 
count was 220 and 798  cells/μL for immunodiscord-
ant and immunoconcordant HIV-infected individuals 
respectively (p  <  0.0001), reflecting the blunted dynam-
ics of CD4 T-cell recovery of the former group. Abso-
lute CD8 T-cell counts showed no differences between 
HIV-infected groups. Median length of HIV infection 
(from diagnosis) was 11.8 and 10.1 years (p = ns), while 
median time on treatment was 11.2 and 5.2 years (p = ns) 
for immunoconcordant or immunodiscordant subjects, 
respectively. Overall, immunodiscordant individuals 
showed the previously reported higher CD4 T-cell death 
and activation with significantly lower nadir CD4 T-cell 
counts [8, 17]. However, some immunoconcordant indi-
viduals showed also low nadir values. To evaluate the 
effect of nadir on immune recovery, immunoconcordant 
individuals were further divided according to the median 
nadir CD4 T-cell value (cut-off value 250 CD4 T cells/
μL) into two subgroups with low and high nadir values 
(n = 17 ad n = 16, respectively). This allowed the direct 
comparison of immunoconcordant individuals with 












































































Figure 1 Characterization of CD4 T‑cell subsets. a shows the evolu‑
tion of CD4 T‑cell counts in the three groups defined in this study 
(Immunodiscordant in red (n = 23), immunoconcordant with low and 
high nadir in dark and light green, m = 17 and n = 16, respectively). 
Dots correspond to individual determinations of CD4 T‑cell counts 
and lines show non‑lineal regression of data plotted for comparative 
purposes. b The absolute count of circulating and TN, TCM, TTM, TEM 
and TTD CD4 T cells was analyzed in immunodiscordant individuals 
(red boxes), immunoconcordant individuals with low or high nadir 
(LN and HN; dark and light green boxes, respectively) and healthy HIV 
uninfected individuals (n = 11, blue boxes). c The frequencies of the 
above‑mentioned subsets in the CD4 T‑cell compartment were also 
analyzed. In panels b and c, data shown correspond to median values 
(band), IQR (boxes) and 10–90 interquartile values (whiskers). Figure 
show significant p values (permutation test adjusted by false discov‑
ery rate): *p < 0.05; **p < 0.01 and ***p < 0.005.
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effect of nadir and enabling us to evaluate the impact of 
low nadir values in immunoconcordant individuals. No 
major differences were observed among immunocon-
cordant subgroups, except for a higher presence of PI-
based treatments and HCV co-infection in the low nadir 
group (Table 1).
Analysis of the CD4 T‑cell maturation
Absolute counts and frequency of different CD4 T-cell 
subsets were analyzed in immunodiscordant, immuno-
concordant (low and high-nadir subgroups) and 11 unin-
fected individuals. The data show that lower CD4 T-cell 
counts in immunodiscordant subjects (Figure  1a) were 
the consequence of lower levels of TN, TCM, TTM and 
TEM cells compared with immunoconcordant individuals, 
while the absolute numbers of TTD cells were similar in 
all groups (Figure 1b). Interestingly, immunoconcordant 
patients, irrespective of the nadir values showed simi-
lar counts of all subsets that were in turn comparable to 
uninfected controls except for the TEM subset, suggesting 
a proper recovery of the CD4 T-cell subsets in these indi-
viduals (Figure 1b). The frequency of each subset in the 
CD4 T-cell compartment showed a significant underrep-
resentation of TN cells in immunodiscordant subjects (as 
compared to concordant or HIV-uninfected individuals) 
that was compensated by an overrepresentation of TTM 
cells and a less evident but still significant increase in TEM 
and TTD cells (Figure 1c). Conversely, TCM cells showed 
Table 1 Main characteristics of the different groups
a Comparison of concordant and discordant subjects. * denotes p < 0.05; ns non significant (Mann–Withney U or Fisher exact test).
b Comparison of concordant subjects with low and high nadir. * denotes p < 0.05; ns non significant (Mann–Withney U or Fisher exact test).
Discordant (n = 23) a Concordant b Uninfected (n = 11)
All (n = 33) Low Nadir (n = 17) High Nadir (n = 16)
Age (years), Median [IQR] 48 [45–50] ns 45 [38–49] 48 [42–52] 42 [37–45] ns 38 [34–47]
Gender (% of male) 91 ns 85 76 94 ns 55
Time since HIV diagnosis 
(years), Median [IQR]
10.1 [4.1–20.4] ns 11.8 [7.5–16.6] 12.2 [8.9–17.4] 11.6 [4.9–13.4] ns –
Time on HAART (years), 
Median [IQR]
5.2 [3.5–11.4] ns 11.2 [7.4–12.6] 11.4 [8.8–12.6] 10.6 [3.7–12.8] ns –
Current HAART (% PI‑based) 70 * 33 41 25 * –
HCV coinfection (%) 35 ns 21 36 15 * 0
Ratio CD4/CD8, Median [IQR] 0.23 [0.17–0.33] * 0.87 [0.60–1.11] 0.76 [0.54–0.87] 1.06 [0.86–1.1] ns 1.64 [1.31–1.81]
CD4 T cell counts (cells/µL), 
Median [IQR]
220 [192–253] * 798 [600–998] 703 [600–896] 881 [672–1,075] ns 779 [629–1,072]
Nadir (cells/µL), Median [IQR] 64 [15–122] * 239 [76–345] 76 [19–185] 351 [280–429] * –
CD4 T‑cell gain (cell/µL/year 
HAART), Median [IQR]
27 [9–54] * 53 [46–102] 53 [46–93] 53 [36–124] ns –
CD4 T cell (% of lymph), 
Median [IQR]
14 [10–17] * 31 [27–39] 29 [27–33] 37 [29–40] ns 42 [36–45]
CD4 T‑cell death (%), Median 
[IQR]
9.3 [7.5–15.1] * 4.6 [3.3–5.9] 4.9 [4.4–5.6] 4.3 [2.9–6.1] ns 4.0 [3.2–4.7]
CD38+CD45RA− (% of CD4 T 
cells), Median [IQR]
37 [29–41] * 25.7 [20–32] 26.5 [20–32] 25.1 [20–31] ns
HLA‑DR+CD95+ (% of CD4 T 
cells), Median [IQR]
16 [7.7–21.6] * 4.5 [3.7–6.7] 4.7 [4.2–6.3] 4.4 [3.2–7.1] ns 2.0 [1.5–2.7]
CD8 T cell counts (cells/µL), 
Median [IQR]
940 [754–1,146] ns 908 [771–1,239] 1,118 [855–1,380] 811 [637–1,121] ns 459 [433–548]
CD8 T cell (% of lymph), 
Median [IQR]
56 [51–61] * 38 [34–46] 39 [36–47] 36 [32–40] ns 24 [23–27]
CD8 T cell death (%), Median 
[IQR]
7.1 [4.8–10.3] ns 6.5 [5.0–12.4] 8.8 [6.1–11.0] 6.1 [4.8–14.9] ns 3.9 [3.4–4.9]
CD38+CD45RA− (% of CD8 T 
cells), Median [IQR]
31 [23–36] * 23 [19–35] 25 [21–36] 21 [19–26] ns 9 [5–13]
HLA‑DR+CD95+ (% of CD8 T 
cells), Median [IQR]
12.6 [6.9–22.4] ns 9.1 [5.6–13.0] 9.8 [5.4–13.6] 8.5 [5.6–13.0] ns
sCD14 (µg/mL), Median [IQR] 8.4 [7.7–10.2] ns 8.8 [7.2–9.7] 9.2 [7.6–10.1] 8.0 [7.1–9.2] ns 4.2 [3.9–4.6]
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similar values in all groups. Again, both subgroups of 
immunoconcordant subjects showed similar values of 
subset frequencies reaching the levels of HIV-uninfected 
controls (Figure 1c).
CD4 T‑cell maturation and CD4 T‑cell death
In our previous studies we have shown that CD4 T-cell 
death, in particular intrinsic apoptosis, is a major deter-
minant of immune recovery [8, 17]. Therefore, we 
explored the association of unbalanced CD4 T-cell mat-
uration with the rate of cell death in ex vivo cultures of 
fresh PBMC. Spontaneous CD4 T-cell death was unre-
lated to the frequency of CD4 TCM or TTD cells but 
showed a significant negative correlation with the fre-
quency of CD4 TN and positive correlation with TTM 
and TEM cells (Figure  2a). Since the frequency of CD4 
TN and TTM cells were strongly inversely correlated (data 
not shown), we addressed independent associations by 
using a model including data from all subsets. This model 
(Additional file  2: Table  S1) confirmed the independent 
positive association of CD4 T-cell death with the fre-
quency of TTM CD4 T cells, clearly linking the higher 
presence of these cells with the increased cell death 
observed in immunodiscordant individuals.
However, these data do not discriminate whether TTM 
cell death rate is similar among treated HIV infected indi-
viduals or is higher in immunodiscordant patients. To 
experimentally confirm these possibilities, we addressed 
the analysis of the lifespan of TN, TCM, TTM and TEM+TD 
CD4 T-cells from immunoconcordant and immunodis-
cordant individuals. Since PBMC culture did not allow 
for a direct assessment of cell death occurring in differ-
ent CD4 T-cell subsets due to phenotypic changes upon 
cell death [21], we chose a previously reported sorting 
strategy prior to ex  vivo culture to approach this issue 
[21]. Although this strategy may induce some additional 
stress to sorted cells, it allowed for a consistent measure 
of subset cell death (Figure 2b). In this set of experiments, 
we observed that TN cells showed significantly lower cell 
death rates than those observed in purified memory cells 
in both groups (Figure  2c). No significant difference in 
TN cell death was observed between groups. However, 
memory cells in immunodiscordant individuals showed 
higher rates of death (Figure 2c). This was associated with 
higher sensitivity to cell death in TCM cells from immu-
nodiscordant individuals (p = 0.056), and non-significant 
trends in TTM and TEM+TD cells. Consistently, TN cell 
death did not correlate with CD4 T-cell counts while a 
significant negative association (p = 0.013) was observed 
for TCM and trends were noticed for TTM and TEM+TD cell 
death (p = 0.067 and 0.054, respectively; Figure 2d). No 
significant correlations with senescence markers could be 
identified (data not shown).
To evaluate the impact of higher cell death rates on 
transition from TCM to more advanced stages of CD4 
T-cell maturation, we analyzed the ratio between TCM 
and TTM cells. This parameter was significantly lower 
in immunodiscordant subjects compared to immuno-
concordant (irrespective of nadir values) or uninfected 
individuals (Figure 3a). Interestingly, TCM to TTM transi-
tion is not completely normalized in immunoconcordant 
individuals (Figure  3a), suggesting that this parameter 
could be useful to assess the quality of immune recovery. 
Reinforcing the relevance of the TCM/TTM ratio, a strong 
negative correlation was observed between this parame-
ter and spontaneous CD4 T-cell death (Figure 3b). Over-
all, our data suggest that memory, but not TN cells, are 
major contributors to the increased cell death observed 
in immunodiscordant individuals [17]. Higher sensitivity 
to death of memory cell populations, especially TCM, may 
help to explain the inability of immunodiscordant indi-
viduals to recover proper TCM/TTM ratios.
CD57 expression and immune recovery
Besides TCM or TTM dysfunction, replicative immunose-
nescence of CD4 T cells has also been related to immune 
recovery [14]. In our cohort, analysis of the frequency of 
CD28−CD57+ CD4 T cells (Additional file 1: Figure S1) 
showed higher levels in immunodiscordant subjects 
than in both immunoconcordant subgroups, which in 
turn showed similar levels to HIV-uninfected individuals 
(Figure  4a). The analysis of CD57 expression in the dif-
ferent CD4 T-cell subsets showed that despite apparent 
full immune recovery, immunoconcordant individuals 
displayed higher CD57 expression than uninfected con-
trols in all CD4 T-cell subsets. In addition, immunodis-
cordant individuals showed highly significant differences 
with concordant subjects particularly in TN and TCM cells 
(Figure 4b).
We also evaluated the relationship of CD57 expres-
sion with CD4 T-cell survival. No significant cor-
relation was found between replicative senescence 
(CD28−CD57+ cells) and spontaneous CD4 T-cell death 
(Figure 4c). These data suggest that different mechanisms 
regulate the expression of CD57 in different CD4 T-cell 
subsets and show that replicative senescence is not cou-
pled with the spontaneous CD4 T-cell death rate charac-
teristics of immunodiscordant responses to HAART.
Analysis of the CD8 T‑cell compartment
Major comorbidities in HIV infected individuals have 
been related to CD8 T-cell activation [1, 22] and recently 
to the CD4/CD8 T-cell ratio. Therefore, we also evaluated 
differentiation and immunosenescence in CD8 T cells. 
Elevated CD8 T-cell counts in HIV infected individuals 
analyzed in this study (Table 1) were the consequence of 
Page 6 of 11Massanella et al. J Transl Med  (2015) 13:230 
an expansion of all subsets except CD8 TCM cells (Fig-
ure 5a). Comparison of immunodiscordant and immuno-
concordant subjects exclusively showed differences in the 
TN subset, consistent with the widely described thymic 
dysfunction of these patients [6]. The percentage of CD8 
T cells was not normalized in immunoconcordant indi-
viduals, which showed intermediate values between 
immunodiscordant and uninfected subjects (Table  1). 
Among immunoconcordant and immunodiscord-
ant individuals, TTM, TEM and TTD CD8 T-cell subsets 
showed similar frequencies. However, a decreased size 
of the CD8 TN subset was observed in immunodiscord-
ant individuals, while a reduced TCM subset was only 
observed in immunoconcordant subjects (Figure  5b). 
Replicative immunosenescence (CD28−CD57+ cells) 
was increased in both groups of HIV infected individuals 
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Figure 2 Association of CD4 T‑cell maturation with CD4 T‑cell death. a Relationships between the frequencies of the different CD4 T‑cell subsets 
was plotted against spontaneous intrinsic CD4 T‑cell apoptosis. Data from immunodiscordant (n = 23, red), low nadir immunoconcordant (n = 17, 
dark green) or high nadir immunoconcordant individuals (n = 16, light green) are shown with color‑coded linear regression for each data set. Linear 
regression for the global data is shown by black lines. Correlation coefficients and p values of Spearman’s test for the global analysis are shown in 
each plot. b Spontaneous cell death was assessed in sorted TN, TCM, TTM, TEM/TTD CD4 T cells stained with the potentiometric probe DIOC(6). Dot 
plots of DIOC(6) and CD3 staining for a representative individual show the percentage of dead cells in the left (DIOC low) gate. c The level of sponta‑
neous cell death in sorted TN, TCM, TTM, TEM+TD T cells from immunoconcordant (green, n = 5) or immunodiscordant (red, n = 5) treated HIV infected 
individuals are shown. Figure shows median values (bands), IQR (boxes) and 10‑90 interquartile values (whiskers). Asterisks denote significant differ‑
ences (non parametric permutation or Mann–Whitney tests). d Correlations of cell death sorted TN, TCM, TTM and TEM/TTD CD4 T cells with absolute 
counts of circulating CD4 T cells. Correlation coefficient and p values (Spearman) are shown in each graph.
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compared to uninfected controls; however, no differences 
between immunoconcordant and immunodiscordant 
individuals were observed. A deeper analysis of CD57 
expression in the different CD8 T-cell subsets commonly 
showed a lower expression of CD57 in uninfected donors 
compared to HIV infected groups, with no differences 
between immunodiscordant and immunoconcordant 
individuals (Figure 5c). Again, we observed similar CD57 
expression when this latter group was subdivided accord-
ing to nadir values of CD4 T-cell counts. In summary, 
individuals displaying different CD4 T-cell recovery 
profiles seem to have similar CD8 T-cell compartments, 
except for the number of CD8 TN cells.
Discussion
Immunodiscordant responses to HAART are associ-
ated with high risk of mortality and the occurrence of 
AIDS and non AIDS-related diseases [23–28]. Although 
blunted CD4 T-cell recovery has been associated with 
impaired thymic output [29], other factors affecting 
memory cell populations, such as activation, replicative 
immunosenescence [30], skewed T-cell maturation [15, 
30, 31] and increased rates of CD4 T-cell death [8, 17], 
may contribute to persistently low CD4 T-cell counts.
The pivotal role of TN cells in CD4 T-cell repopula-
tion and the lower size of this subset in immunodis-
cordant individuals has been universally reported [5, 10, 
32, 33] and has been confirmed in our cohort using the 
CD31 marker (CD45RA+CD31+ percentage of CD4 T 
cells) [17]. However, the thymus hypothesis should not 
overlook the role of memory cell populations, which may 
maintain T-cell homeostasis in thymectomyzed SIV-
infected animals [11]. Immunodiscordant individuals 
show low proliferation of TN cells [15], suggesting that TN 
cells might be not required for CD4 T-cell repopulation 
(Additional file 3: Figure S2). In the absence of new CD4 
TN cells, memory cells should be expanded by homeo-
static mechanisms involving IL-7 or TCR stimulation to 
maintain CD4 T-cell numbers [34, 35]. Since CD4 TCM 
cells are the main target of IL-7 [36] and IL-7 levels are 
increased in our cohort of immunodiscordant individuals 
[37], the inability to recover CD4 T cells, could also be 
related to the limited expansion capacity of memory cells. 
It could be argued that the CD4 TCM cell subset is under 
strong homeostatic pressure. Supporting this notion, 
high TCM proliferation have been reported in immuno-
discordant individuals [15]. However, the limited size of 
this subset in immunodiscordant patients indicates that 
the proliferation of CD4 TCM cells may be inefficient or 
may result in increased maturation towards TTM or TEM 
phenotypes. This could explain the relative accumulation 
of CD4 T cells in intermediate stages of differentiation, 
mainly TTM but also TEM cells, observed in our cohort 
of immunodiscordant individuals. Interestingly, our data 
show an association between the levels of CD4 TTM cells 
and the rate of spontaneous CD4 T-cell death, although 
the analysis of cell death in sorted CD4 T-cell subsets in 
immunodiscordant and immunoconcordant individuals 
indicates that CD4 TCM cell death is better correlated to 
CD4 T-cell recovery. Our data suggest that reduced TCM 







































Figure 3 Ratio CD4 TCM/TTM and its association with total CD4 T‑cell death. a The ratio between TCM and TTM cells was calculated as a measure of 
CD4 T‑cell differentiation. Data shown correspond to median values (bands), IQR (boxes) and 10–90 interquartile values (whiskers) for immunodis‑
cordant individuals (n = 23, red boxes), immunoconcordant individuals with low or high nadir (n = 17 and n = 16, dark and light green boxes, respec‑
tively) and healthy HIV uninfected individuals (n = 11, blue boxes). Figure shows significant p values (permutation test adjusted by false discovery 
rate). b Correlation between total CD4 T‑cell death and the ratio of CD4 TCM/TTM cells. P values for Spearman’s test correlation are shown in black for 
all data points, and in red or green for immunodiscordant and immunoconcordant individuals respectively.
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survival may be a second mechanism that adds to low 
thymic output in immunodiscordant patients.
An additional consequence of the high cell death level 
of TCM and the trends detected in TTM or TEM cells in 
immunodiscordant patients is the modest accumulation 
of senescent CD4 T cells. Since the fate of CD4 TCM and 
TTM or TEM could be cell death rather than further matu-
ration (Additional file 3: Figure S2), this fact could explain 
the poor relationship between immunodiscordance and 
replicative senescence. Regarding senescence, our data 
on CD57 expression are consistent with previous reports 
[29], revealing higher levels of CD28–CD57+CD4 T 
cells in immunodiscordant individuals. Although some 
reports suggest that CD57+ CD4 T-cells undergo faster 
spontaneous apoptosis [38], the frequency of these cells 
is not associated with cell death rate in the CD4 T-cell 
compartment, suggesting that they are unlikely to drive 
increased cell death in immunodiscordant individuals. 
Consistently, several authors suggest that CD28−CD57+ 
cells are long lived [39, 40]. Aside from replicative senes-
cence, the expression of CD57 in other CD4 T-cell sub-
sets, namely CD4 TN cells, has been also associated with 
CD4 T-cell recovery [30]. Although we have also noticed 
this association, it remains unclear whether CD57+ cells 
in TN and TCM subsets are actually senescent [12], or 
reflect other T-cell functions or subsets such as Follicular 
helper CD4 T-cells (TFh), which express CD57 [41] and 
are recovered after HAART [42]. The increased expres-
sion of CD57 in CD4 TN and TCM cells from immunodis-
cordant individuals points to alterations in these subsets 
and suggests again a role for TCM cells in CD4 T-cell 
recovery.
Our data point out that the level of destruction of 
the immune system, as measured by the nadir CD4 
T-cell count, which has been widely associated with 





























































































Figure 4 Characterization of CD57 expression in CD4 T cells. a The replicative senescence of the whole CD4 T‑cell compartment was defined by 
the frequency of CD57+CD28− cells. b In addition, the expression of CD57+ cells was evaluated in the different CD4 T cell subsets by analyzing the 
frequency of CD57+ cells. c The relationship between levels of spontaneous CD4 T‑cell death and replicative immunosenescence is shown. Plots 
shows data from immunodiscordant (n = 23, red), low nadir immunoconcordant (n = 17, dark green) or high nadir immunoconcordant individu‑
als (n = 16, light green) with color‑coded linear regression for each data set. Linear regression for the global data is shown in black lines. Correlation 
coefficients and p values of Spearman’s test for the global analysis are shown. a, b also show data from HIV uninfected individuals (n = 11, blue bars).
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immunodiscordant responses. Indeed, some individu-
als with low nadir values are able to recover the CD4 
T-cell compartment to the same extent as subjects with 
higher nadir values, at least in respect to maturation 
phenotypes. Although this observation does not occlude 
the fact that starting HAART with low CD4 T-cell counts 
increases the risk of immunodiscordant responses, 
it suggests that not only the number but also the qual-
ity of CD4 T cells determine immune reconstitution. In 
this regard, it is tempting to speculate that the size of the 
TCM compartment prior to HAART may yield a better 
predictive value [16].
We have also shown that despite the impairment/fail-
ure of thymic output in both CD4 and CD8 T-cell sub-
sets, only CD4 T cells show an unbalanced maturation 
profile. While minimal differences were observed among 
HIV infected groups in CD8 T cells. This result is sur-
prising since CD8 T-cell senescence or activation has 
also been related to clinical progression in treated HIV 
infected individuals [43, 44]. Moreover, a recent analy-
sis of HIV infected individuals failing to recover CD4/
CD8 T-cell ratios after HAART also points to matura-
tion and activation of CD8 T cells as major markers of 
poor immune recovery [45]. This apparent paradox could 
be related to the different pressures acting on CD4 and 
CD8 T cells or to the specific features of our cohort, 
which exclusively included long-term treated individu-
als (more than 2 years) without AIDS defining events. It 
remains possible that we have selected individuals with 
low risk of clinical progression, potentially minimizing 
differences in CD8 T cells. On the other hand, our selec-
tion criteria and classification cutoff, based exclusively 
in CD4 T-cell counts, allows for the direct comparison 
of the CD4 T-cell compartment between groups, avoid-
ing the confounding effects of inflammatory and clini-
cal status. In contrast, our analysis has some limitations. 
First, inclusion criteria might select immunodiscordant 
patients with a trend towards a lower treatment time 
(see Table 1). However, correcting maturation and senes-
cence analyses for time on treatment did not modify the 
main conclusions of the study (not shown). A second 
limitation comes from the definition of immunodiscord-
ant responses. We have used a cutoff value of 350 CD4 
T cells/µL, while other authors define the limit in higher 
values. To assess the robustness of our analysis, a cutoff 
of 500 CD4 T cells/µL has been also used, yielding simi-
lar results (data not shown). Finally, another confound-
ing factor relevant in the context of this study is CMV 
co-infection, a major driver of immunosenescence. How-
ever, all HIV infected individuals and 9 out of 11 unin-
fected individuals recruited were seropositive for CMV 
infection. Exclusion of CMV seronegative controls did 
not modify our analysis.
Conclusions
In summary, our data point to a major perturbation of 












































































Figure 5 Characterization of CD8 T‑cell subsets. The absolute 
number of circulating and TN, TCM, TTM, TEM and TTD CD8 T cells (a) was 
analyzed in immunodiscordant individuals (n = 23, red boxes), immu‑
noconcordant individuals with low or high nadir (n = 17 and n = 16, 
dark and light green boxes, respectively) and healthy HIV uninfected 
individuals (n = 11, blue boxes). The frequency of the above‑men‑
tioned subsets in the CD8 T cell compartment (b) was also analyzed. 
The expression of CD57+ cells was further evaluated in the differ‑
ent subsets by the frequency of CD57+ cells (c). In all panels data 
shown correspond to median values (bands), IQR (boxes) and 10–90 
interquartile values (whiskers) for immunodiscordant individuals (red 
boxes), immunoconcordant individuals with low or high nadir (green 
boxes) and healthy HIV uninfected individuals (blue boxes). Figure 
show p values (permutation test adjusted by false discovery rate).
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characteristic of immunodiscordant responses to 
HAART. This perturbation adds to the increased accu-
mulation of senescent cells and to the poor thymic out-
put, and points to CD4 TCM and TTM cells as the major 
players of CD4 T-cell repopulation.
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